Latest filing published 29 Jun 2018 for MedReleaf Corp., €549k.
No signal scores available.
Michael Dacks appears in our data through filings on MedReleaf Corp. shares, published by SEDI. In total, 3 filings cover trades dated from 1 April 2018 to 25 June 2018.
No open-market purchase appears, only 1 sale worth €549k. Outside the open market, there are 1 option exercise.
The newest entry dates from 29 June 2018: an option exercise of €549k, in MedReleaf Corp. Typically, a trade is published a median of 4 days after it takes place. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations